Solara Active Pharma Sciences has informed that it enclosed revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August 29, 2024 for Pronomz Ventures LLP.
The above information is a part of company’s filings submitted to BSE.